XK
ESPR

Xact Kapitalforvaltning’s Esperion Therapeutics ESPR Stock Holding History

Xact Kapitalforvaltning’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,358
Closed -$260K – 1329
2019
Q4 		$260K Buy
+4,358
New +$196K ﹤0.01% 1299
2019
Q3 		– Sell
-4,358
Closed -$203K – 1433
2019
Q2 		$203K Buy
+4,358
New +$205K ﹤0.01% 1381
2019
Q1 		– Sell
-4,358
Closed -$200K – 1477
2018
Q4 		$200K Buy
+4,358
New +$210K 0.01% 1436
2018
Q2 		– Sell
-3,458
Closed -$250K – 1585
2018
Q1 		$250K Buy
+3,458
New +$254K 0.01% 1360

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return